Around the World

It is now widely known that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), spreads via respiratory droplets. The persistence of the aerosol in the environment largely determines the success of the viral transmission. In addition, the virus-laden droplets can also deposit on various surfaces
0 Comments
St. Jude Children’s Research Hospital scientists have developed an integrated, high-throughput system to better understand and possibly manipulate gene expression for treatment of disorders such as sickle cell disease and beta thalassemia. The research appears today in the journal Nature Genetics. Researchers used the system to identify dozens of DNA regulatory elements that act together
0 Comments
A team of scientists in Australia has recently investigated the health condition of Australian citizens who lost jobs during the coronavirus disease 2019 (COVID-19) pandemic. The study findings reveal that job loss is associated with a deterioration in mental health but an improvement in physical health. Importantly, retaining employment has shown a positive impact on
0 Comments
It is still unclear how the immune system’s antibodies target and attack certain viruses, particularly the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen that causes the coronavirus disease (COVID-19). In a new study recently published in the journal Science, a team of researchers in the U.S. found that most of the antibodies
0 Comments
A Yale-led study reveals that new medicines and vaccines approved for use in the United States are often unavailable in countries that hosted their clinical trials, suggesting that the benefits of drug research are not being shared equitably among populations that participate in testing. The study, published May 5 in JAMA Network Open, covers 34
0 Comments
Black patients from disadvantaged neighborhoods were significantly more likely to die within five years of surviving a heart attack compared with Black heart attack patients from wealthier neighborhoods and white patients of any socioeconomic means who survive a heart attack, according to a study being presented at the American College of Cardiology’s 70th Annual Scientific
0 Comments
A new study published in the British Journal of Clinical Pharmacology provides insights on how common hospitalized patients develop liver injury from taking different medications. When investigators analyzed the records of 156,570 hospitalized patients, they found 499 cases of drug-induced liver injury (DILI), for an incidence of 0.32%. Anti-infective agents, cancer medications, and nonsteroidal anti-inflammatory
0 Comments
Volunteer firefighters — who comprise more than 65 percent of the U.S. fire service — have higher levels of “forever chemicals,” per- and polyfluoroalkyl substances (PFAS), in their bodies than the general public, according to a Rutgers study. The study, which was published in the International Journal of Environmental Research and Public Health, compared the
0 Comments
A new study, presented today at the AATS 101st Annual Meeting, and simultaneously published in the Journal of the American College of Cardiology, finds that patients suffering from severe mitral regurgitation should be carefully screened and counselled before undergoing transcatheter edge-to-edge mitral repair (TEER). Data showed that up to 95 percent of patients who needed
0 Comments
Changi General Hospital (CGH) and the Singapore University of Technology and Design (SUTD) have developed the Blood WArning Technology with Continuous Haemoglobin (BWATCH) sensor, a lightweight monitoring device placed over a patient’s bandage that detects real-time bleeding from wound sites following invasive medical procedures. BWATCH was tested and validated in an observational clinical trial involving
0 Comments
A Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center found that BK virus (BKV)-specific T cells from healthy donors were safe and effective as an off-the-shelf therapy for BKV-associated hemorrhagic cystitis (BKV-HC), a painful complication common after allogeneic stem cell transplants for patients with leukemia or lymphoma. The
0 Comments
Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.   Chronic kidney disease is an important public health issue, and there is
0 Comments